Want to join the conversation?
$LRCX's EPS came in at the high-end of the guidance range. During calendar year 2015, the company generated over $1.2Bil in cash from operations, which was an increase of more than 45% vs. calendar year 2014. $LRCX returned more than $410MM to shareholders through stock repurchases and dividends.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.